Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.52% vs -2.33% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -3.17% vs 0.00% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -57.14% vs -7.46% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -23.53% vs 88.89% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Jinling Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.52% vs -2.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -4.53% vs 23.13% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -3.17% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.33% vs -16.82% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -57.14% vs -7.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 357.14% vs -121.41% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -23.53% vs 88.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 225.00% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






